BioCentury | Jan 29, 2009
Targets & Mechanisms

Breaking the biofilm barrier

Bacterial biofilms compromise the use of implanted medical devices such as stents, catheters and ventilators because they can shed bacteria and cause infection elsewhere in a patient. These surface-attached bacterial communities are very difficult to...
BioCentury | Jan 15, 2009
Distillery Therapeutics

Indication: Infectious disease

This week in therapeutics Indication Target/ marker/ pathway Summary Licensing status Publication and contact information Infectious disease Pseudomonas Fucose-binding lectin PA-IIL (lecB) A study in cell culture identified lecB-binding peptide dendrimers that may be useful...
BioCentury | Dec 23, 1996
Emerging Company Profile

Quantum Biotechnologies Inc.

...INRA/CNRS (France) Number of employees: 19 Funds raised: C$9.7 million Investors: BioCapital, MSP, Sofinnova, Innolion, EMV...
Items per page:
1 - 3 of 3
BioCentury | Jan 29, 2009
Targets & Mechanisms

Breaking the biofilm barrier

Bacterial biofilms compromise the use of implanted medical devices such as stents, catheters and ventilators because they can shed bacteria and cause infection elsewhere in a patient. These surface-attached bacterial communities are very difficult to...
BioCentury | Jan 15, 2009
Distillery Therapeutics

Indication: Infectious disease

This week in therapeutics Indication Target/ marker/ pathway Summary Licensing status Publication and contact information Infectious disease Pseudomonas Fucose-binding lectin PA-IIL (lecB) A study in cell culture identified lecB-binding peptide dendrimers that may be useful...
BioCentury | Dec 23, 1996
Emerging Company Profile

Quantum Biotechnologies Inc.

...INRA/CNRS (France) Number of employees: 19 Funds raised: C$9.7 million Investors: BioCapital, MSP, Sofinnova, Innolion, EMV...
Items per page:
1 - 3 of 3